SVBI — AGM Information 2024

Aug 5, 2024

SciVision Biotech Inc.

2024 General Shareholders' Meeting

The 2024 General Shareholders’ Meeting (the “Meeting”) of SciVision Biotech Inc. (the “Company”) will be convened at 09:00 a.m., Wednesday, June, 26, 2024 (the time for shareholders' registration starts at 8:30a.m. at the meeting venue) at No. 12, Fuxing 4th Road, Qianzhen District, Kaohsiung City(Atrium Saloon, Building A, South District, Kaohsiung Software Technology Park) Convene Format: Physical Shareholders’ Meeting

1. The agendas for the Meeting are as follows:

2. I. Reports

   • (1) 2023 Business Report.

   • (2) Audit Committee’s Review Report on 2023 Financial Statements.

   • (3) 2023 Remuneration for Employees and Directors.

   • (4) Execution report on the 2nd Domestic Unsecured Convertible Corporate Bond

   • (5) Appropriation of 2023 Earnings and Cash Distribution for Capital Surplus.

3. II. Ratifications

   • (1) Ratification of 2023 Business Report and Financial Statements.

   • (2) Ratification of the Proposed Distribution of 2023 Earnings.

4. III. Discussions

Proposed Partial Amendments to the "Articles of Incorporation"

• IV. Extempore Motions

• Shareholders can go to the Company's website > Investor Relations > Shareholder Services (view at https://www.scivision.com.tw/) to view the "2024 General Shareholders' Meeting Video" after the Shareholders' Meeting.

• The Company intends to appropriate cash dividends of approximately NT$2.5 per share (earnings appropriation of NT$2.3699 per share and capital surplus appropriation of NT$0.1301 per share). Once the motion is approved by the general shareholders' meeting, it is proposed to authorize the Chairman to set the record date for allocating cash dividends, and to authorize the Chairman with full power to handle changes in the Company's outstanding shares that affect the dividend rate per share.

• If there exist any matters that shall be itemized in the causes and the essential contents thereof shall be explained pursuant to Article 172 of the Company Law, the essential contents can be found at the Market Observation Post System (http:// mops.twse.com.tw). Please log into said website, and click

• “electronic books”, key in the Year “2024,” select the code of the Company “1786,” and read references related to the shareholders’ meeting.

• In accordance with section 165 of the Companies Act, the transfer of shares was suspended from April 28, 2024 to June 26, 2024

• The shareholder’s voting power of this annual shareholders' meeting may be exercised by way of electronic transmission, and the exercising period will be from May 27, 2024 through June 23, 2024. Please log in the “Stockvote” established by Taiwan Depository & Clearing Corporation at https://stockservices.tdcc.com.tw.

• The institution for tallying and verifying proxy forms of 2024 general shareholders’ meeting is Stock Registration Department, HORIZON SECURITIES CO., LTD.

Board of Directors

SciVision Biotech Inc.